Skip to content
healthcare.dev

Hydroxyzine Pamoate

NDC 51655-252, Hydroxyzine Pamoate, capsule, from Northwind Health Company, LLC.

Product NDC
51655-252
Status
Listed
Labeler
Northwind Health Company, LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA088487
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51655-252 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDROXYZINE PAMOATE50 mg/1

Pharmacologic classes

Antihistamine [EPC]; Histamine Receptor Antagonists [MoA]

Package NDCNDC-11Package
51655-252-525165502525230 CAPSULE in 1 BOTTLE, PLASTIC (51655-252-52)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/faf7932b-40ee-8822-e053-6394a90a5e40

Use it

Look up 51655-252 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51655-252 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51655-252. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.